Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Nunes

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
NEJM Evidence|November 5, 2025
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact SitesMelinda Gooderham, Edward Lain, Robert Bissonnette, et al.
Lancet (London, England)|September 21, 2025
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trialsLinda Stein Gold, April W Armstrong, Robert Bissonnette, et al.
Cancer Research|March 9, 2005
Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancerEduardo M Reis, Elida P B Ojopi, Fernando L Alberto, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
NEJM Evidence|November 5, 2025
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact SitesMelinda Gooderham, Edward Lain, Robert Bissonnette, et al.
Lancet (London, England)|September 21, 2025
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trialsLinda Stein Gold, April W Armstrong, Robert Bissonnette, et al.
Cancer Research|March 9, 2005
Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancerEduardo M Reis, Elida P B Ojopi, Fernando L Alberto, et al.
Pageof 2